FR2290219A1 - Principe actif de vaccin antipyocyanique - Google Patents

Principe actif de vaccin antipyocyanique

Info

Publication number
FR2290219A1
FR2290219A1 FR7436747A FR7436747A FR2290219A1 FR 2290219 A1 FR2290219 A1 FR 2290219A1 FR 7436747 A FR7436747 A FR 7436747A FR 7436747 A FR7436747 A FR 7436747A FR 2290219 A1 FR2290219 A1 FR 2290219A1
Authority
FR
France
Prior art keywords
antisera
vaccines
liq
bacterium
collecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7436747A
Other languages
English (en)
Other versions
FR2290219B1 (fr
Inventor
P Berche
R Tinelli
M Veron
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Priority to FR7436747A priority Critical patent/FR2290219A1/fr
Publication of FR2290219A1 publication Critical patent/FR2290219A1/fr
Application granted granted Critical
Publication of FR2290219B1 publication Critical patent/FR2290219B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1214—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR7436747A 1974-11-05 1974-11-05 Principe actif de vaccin antipyocyanique Granted FR2290219A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7436747A FR2290219A1 (fr) 1974-11-05 1974-11-05 Principe actif de vaccin antipyocyanique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7436747A FR2290219A1 (fr) 1974-11-05 1974-11-05 Principe actif de vaccin antipyocyanique

Publications (2)

Publication Number Publication Date
FR2290219A1 true FR2290219A1 (fr) 1976-06-04
FR2290219B1 FR2290219B1 (fr) 1978-12-29

Family

ID=9144684

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7436747A Granted FR2290219A1 (fr) 1974-11-05 1974-11-05 Principe actif de vaccin antipyocyanique

Country Status (1)

Country Link
FR (1) FR2290219A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0120532A2 (fr) * 1983-03-23 1984-10-03 Brigham And Women's Hospital Vaccin contre Pseudomonas Aeruginosa à base d'exopolysaccharide mucoidique
US4702910A (en) * 1984-05-25 1987-10-27 Mitsui Toatsu Chemicals, Inc. Common antigen (PSC-A) to Pseudomonas aeruginosa which acts as an agent for pretecting Pseudomonas aeruginosa infection
US5114712A (en) * 1985-11-14 1992-05-19 Mitsui Toatsu Chemicals, Inc. Common antigen (PSC-A) to Pseudomonas aeruginosa which acts as an agent for protecting Pseudomonas aeruginosa infection

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0120532A2 (fr) * 1983-03-23 1984-10-03 Brigham And Women's Hospital Vaccin contre Pseudomonas Aeruginosa à base d'exopolysaccharide mucoidique
EP0120532A3 (en) * 1983-03-23 1985-12-18 Brigham And Women's Hospital Mucoid exopolysaccharide vaccine against pseudomonas aeruginosa
AU571495B2 (en) * 1983-03-23 1988-04-21 Brigham And Women's Hospital Mucoid exopolysaccharide vaccine against pseudomonas aeruginosa
US4702910A (en) * 1984-05-25 1987-10-27 Mitsui Toatsu Chemicals, Inc. Common antigen (PSC-A) to Pseudomonas aeruginosa which acts as an agent for pretecting Pseudomonas aeruginosa infection
US5114712A (en) * 1985-11-14 1992-05-19 Mitsui Toatsu Chemicals, Inc. Common antigen (PSC-A) to Pseudomonas aeruginosa which acts as an agent for protecting Pseudomonas aeruginosa infection

Also Published As

Publication number Publication date
FR2290219B1 (fr) 1978-12-29

Similar Documents

Publication Publication Date Title
GB1034123A (en) Absorbable prosthetic devices and surgical sutures
DE2964276D1 (en) Live attenuated human hepatitis-a-virus, method for growing it in cell culture in vitro and composition comprising it
IE46215L (en) Gamma-globulins, immune nucleic acids and immune dialysates.
ES416573A1 (es) Metodo de extraer mucopolisacaridos de tejidos conjuntivos de animales.
JPS6485925A (en) B group ii type streptococci idiosyncratic polysaccharide antigen
GB1384179A (en) Treatment of microorganism cells
FR2290219A1 (fr) Principe actif de vaccin antipyocyanique
GB1263765A (en) A method for the production of protease by cultivating bacteria
DE2962920D1 (en) Attenuated strain of feline infectious peritonitis virus, method for preparing it and vaccine comprising it
Zerner et al. Acetoacetate decarboxylase. Preparation of the enzyme
US4503036A (en) Process for producing a biochemical vaccine against Salmonella infection
De Sanchez et al. Immunological studies on Histoplasma capsulatum
US3793150A (en) Equine strangles vaccine and method of preparing and using the same
Hambleton et al. Vaccine potencies of the live vaccine strain of Francisella tularensis and isolated bacterial components
EP0090660A3 (fr) Vaccin anti-gonococcique
DK128567B (da) Fremgangsmåde til fjernelse af esterase fra et mælkekoagulerende enzym fremstillet ved fermentering af en mikroorganismekultur af slægten Mucor.
CN103554214B (zh) 保持黄孢原毛平革菌菌体形态的胞外聚合物的提取方法
Pappagianis et al. Preparation and property of a complement-fixing antigen from mycelia of Coccidioides immitis
GB1426042A (en) water-soluble immunological adjuvants
FR2189021A1 (en) Non-arthrogenic immunological adjuvants - obtained by extraction of lipid-free mycobacterial residues
FR2091427A5 (en) Nutrient media for microorganisms - by extraction of fresh water alga
Fitzgerald et al. Helically coiled micro-organism from caecum contents of the rat
FR2035795A1 (en) Anti-brucellosis vaccine prepn
ES8200228A1 (es) Metodo para producir preparados medicinales para el trata- miento de carcinomas
SU454251A1 (ru) Способ получени препаратов антигенов кишечных бактерий

Legal Events

Date Code Title Description
ST Notification of lapse